Pharmaceutical After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally this morning confirmed it is accepting previously rejected takeover bids from the USA’s AbbVie much on the lines of the fifth acquisition offer revealed earlier this week, worth around £32 billion ($54 billion), and will recommend it to shareholders. 18 July 2014